Literature DB >> 15932799

Direct stimulation of naïve T cells by antigen-presenting cell vesicles.

Jonathan Sprent1.   

Abstract

T cells are activated through T cell receptor (TCR) recognition of peptidic fragments of antigen bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells (APC). In addition, T cells require a costimulatory signal delivered through contact with other ligands on APC, especially B7 and ICAM-1 which bind to CD28 and LFA-1, respectively, on T cells. Under physiological conditions, T cell activation requires contact with viable APC. Under defined conditions, however, T cells can be activated by exosomes secreted by APC. Evidence will be presented that exosomes can be directly immunogenic for CD8(+) T cells in the absence of normal APC with the proviso that exosomes express a high density of MHC I/peptide complexes as well as B7 and ICAM-1. Similar findings apply to plasma membrane fragments prepared from APC sonicates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932799     DOI: 10.1016/j.bcmd.2005.04.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  22 in total

Review 1.  Immune response to H. pylori.

Authors:  Giovanni Suarez; Victor E Reyes; Ellen J Beswick
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

Review 2.  Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis.

Authors:  Mohammed Alghamdi; Sultan Abdulmughni Alamry; Sami M Bahlas; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

3.  Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells.

Authors:  Atanu K Khatua; Harry E Taylor; James E K Hildreth; Waldemar Popik
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

4.  B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.

Authors:  Melanie A Ruffner; Seon Hee Kim; Nicole R Bianco; Loise M Francisco; Arlene H Sharpe; Paul D Robbins
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

5.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.

Authors:  Jessica Wahlgren; Tanya De L Karlson; Mikael Brisslert; Forugh Vaziri Sani; Esbjörn Telemo; Per Sunnerhagen; Hadi Valadi
Journal:  Nucleic Acids Res       Date:  2012-05-22       Impact factor: 16.971

6.  Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling.

Authors:  Jessica Wahlgren; Tanya De L Karlson; Pernilla Glader; Esbjörn Telemo; Hadi Valadi
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 7.  Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance.

Authors:  L A Smyth; B Afzali; J Tsang; G Lombardi; R I Lechler
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

Review 8.  Extracellular Vesicles and Their Current Role in Cancer Immunotherapy.

Authors:  Carla Giacobino; Marta Canta; Cristina Fornaguera; Salvador Borrós; Valentina Cauda
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 9.  Extracellular vesicle- and particle-mediated communication shapes innate and adaptive immune responses.

Authors:  Fanny A Pelissier Vatter; Michele Cioffi; Samer J Hanna; Ines Castarede; Simone Caielli; Virginia Pascual; Irina Matei; David Lyden
Journal:  J Exp Med       Date:  2021-06-28       Impact factor: 14.307

10.  Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.

Authors:  Sophie Viaud; Magali Terme; Caroline Flament; Julien Taieb; Fabrice André; Sophie Novault; Bernard Escudier; Caroline Robert; Sophie Caillat-Zucman; Thomas Tursz; Laurence Zitvogel; Nathalie Chaput
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.